Surmodics Receives FDA Approval for the SurVeil(TM) Drug-Coated Balloon

Stock Information for Surmodics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Surmodics Inc.

Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
Surmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2
Surmodics Receives FDA 510(k) Clearance for Pounce(TM) LP Thrombectomy System
Surmodics to Participate in the Jefferies Healthcare Conference on June 8
Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce(TM) Thrombectomy System

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.